Since malignant melanomas frequently escape immunosurveillance through MHC-I downregulation, rendering them susceptible to NK cell-mediated killing, we investigated whether NK cells contribute to DHODH inhibition-induced anti-tumor immunity in melanoma. The gene discussed is DHODH; the disease is neoplasm.